Search
Medline Ord Shs Class A
MDLNAdd to Watchlist
35.940USD
-0.480-1.32%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
30.41BMarket Cap
30.31P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
29
analysts
Buy
Current Rating
51.125
Target Price
+42.25%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Medline Ord Shs Class A
MDLN
29
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Medline Ord Shs Class A's expected revenue for the next quarter?
Medline Ord Shs Class A's expected revenue is 7.73B.
How have Medline Ord Shs Class AMDLN's recent earnings per share performed?
The market expectation was USD 0.16, while Medline Ord Shs Class AMDLN's earnings per share (EPS) for the previous quarter was USD 0.21. EPS for the next quarter is expected at USD 0.39.
What is the analyst rating for Medline Ord Shs Class A?
Based on the ratings of Medline Ord Shs Class A's stock from 29 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
